Literature DB >> 26738863

Overexpression of ADAMTS5 can regulate the migration and invasion of non-small cell lung cancer.

Jun Gu1,2, Jie Chen3,4, Jian Feng2, Yifei Liu5, Qun Xue6, Guoxin Mao4, Ling Gai4, Xiaoning Lu6, Rui Zhang2, Jialin Cheng4, Yanxia Hu2, Mengting Shao4, Hong Shen4, Jianan Huang7.   

Abstract

Non-small cell lung cancer (NSCLC) is the major cause of cancer-related lethality among human cancer patients globally, and the poor prognosis of this cancer is mainly explained by metastasis, so it is essential to find out the molecule mechanisms and a novel therapeutic for NSCLC. A disintegrin and metalloprotease with thrombospondin motif 5 (ADAMTS5) belongs to the protease family. It has been reported to participate in tumor migration and invasion. In this study, we showed that the expression of ADAMTS5 was higher in lung cancer tissues by Western blot. The immunohistochemistry analysis was performed in 140 NSCLC cases, and the result indicated that ADAMTS5 was significantly associated with clinical pathologic variables. The Kaplan-Meier curve showed that the high expression of ADAMTS5 was related to poor prognosis of lung cancer patients. Wound healing assays and transwell migration assays revealed that the high expression of ADAMTS5 promoted the migration and invasion of NSCLC. In a word, our findings suggest that ADAMTS5 can regulate the migration and invasion of NSCLC and it may be a useful target of therapy in NSCLC.

Entities:  

Keywords:  ADAMTS5; Invasion; Migration; Non-small cell lung cancer

Mesh:

Substances:

Year:  2016        PMID: 26738863     DOI: 10.1007/s13277-015-4573-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

1.  Interaction of LHBs with C53 promotes hepatocyte mitotic entry: A novel mechanism for HBV-induced hepatocellular carcinoma.

Authors:  Yonghong Lei; Hao Liu; Yuying Yang; Xiaojie Wang; Na Ren; Ben Li; Shunai Liu; Jun Cheng; Xiaobing Fu; Jinqian Zhang
Journal:  Oncol Rep       Date:  2011-10-04       Impact factor: 3.906

Review 2.  The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets.

Authors:  Steven L Wood; Maria Pernemalm; Philip A Crosbie; Anthony D Whetton
Journal:  Cancer Treat Rev       Date:  2013-10-15       Impact factor: 12.111

Review 3.  Lung cancer in 2013: Refining standard practice and admitting uncertainty.

Authors:  Stephen V Liu; Giuseppe Giaccone
Journal:  Nat Rev Clin Oncol       Date:  2014-01-21       Impact factor: 66.675

4.  Human glioblastomas overexpress ADAMTS-5 that degrades brevican.

Authors:  Mitsutoshi Nakada; Hisashi Miyamori; Daisuke Kita; Tomoya Takahashi; Junkoh Yamashita; Hiroshi Sato; Ryu Miura; Yu Yamaguchi; Yasunori Okada
Journal:  Acta Neuropathol       Date:  2005-08-30       Impact factor: 17.088

Review 5.  ADAMs in cancer cell proliferation and progression.

Authors:  Satsuki Mochizuki; Yasunori Okada
Journal:  Cancer Sci       Date:  2007-03-09       Impact factor: 6.716

Review 6.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

7.  A cell-ECM screening method to predict breast cancer metastasis.

Authors:  L E Barney; E C Dandley; L E Jansen; N G Reich; A M Mercurio; S R Peyton
Journal:  Integr Biol (Camb)       Date:  2015-02       Impact factor: 2.192

8.  Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).

Authors:  N Rocks; G Paulissen; F Quesada Calvo; M Polette; M Gueders; C Munaut; J-M Foidart; A Noel; P Birembaut; D Cataldo
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

9.  The phosphoinositide-binding protein ZF21 regulates ECM degradation by invadopodia.

Authors:  Daisuke Hoshino; Makoto Nagano; Anri Saitoh; Naohiko Koshikawa; Takashi Suzuki; Motoharu Seiki
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

10.  ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.

Authors:  Shuhong Shao; Zunling Li; Wei Gao; Guohua Yu; Dexiang Liu; Fang Pan
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more
  6 in total

1.  Epigenetic silencing of ADAMTS5 is associated with increased invasiveness and poor survival in patients with colorectal cancer.

Authors:  Jizhen Li; Yi Liao; Jintuan Huang; Yi Sun; Hao Chen; Chunyu Chen; Senmao Li; Zuli Yang
Journal:  J Cancer Res Clin Oncol       Date:  2017-11-15       Impact factor: 4.553

2.  Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells.

Authors:  Tania Fontanil; Saúl Álvarez-Teijeiro; M Ángeles Villaronga; Yamina Mohamedi; Laura Solares; Angela Moncada-Pazos; José A Vega; Olivia García-Suárez; Marcos Pérez-Basterrechea; Juana M García-Pedrero; Alvaro J Obaya; Santiago Cal
Journal:  Oncotarget       Date:  2017-02-21

3.  Dysregulated lncRNA-miRNA-mRNA Network Reveals Patient Survival-Associated Modules and RNA Binding Proteins in Invasive Breast Carcinoma.

Authors:  Yu Dong; Yang Xiao; Qihui Shi; Chunjie Jiang
Journal:  Front Genet       Date:  2020-01-15       Impact factor: 4.599

4.  Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.

Authors:  Ya-Zhen Zhu; Yi Liu; Xi-Wen Liao; Shan-Shan Luo
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

5.  Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer.

Authors:  Guo-Chen Duan; Xiao-Peng Zhang; Hui-En Wang; Zhi-Kang Wang; Hua Zhang; Lei Yu; Wen-Fei Xue; Zhi-Fei Xin; Zhong-Hui Hu; Qing-Tao Zhao
Journal:  Onco Targets Ther       Date:  2020-03-04       Impact factor: 4.147

6.  Core-shell nanoparticles suppress metastasis and modify the tumour-supportive activity of cancer-associated fibroblasts.

Authors:  Dávid Kovács; Nóra Igaz; Annamária Marton; Andrea Rónavári; Péter Bélteky; László Bodai; Gabriella Spengler; László Tiszlavicz; Zsolt Rázga; Péter Hegyi; Csaba Vizler; Imre M Boros; Zoltán Kónya; Mónika Kiricsi
Journal:  J Nanobiotechnology       Date:  2020-01-21       Impact factor: 10.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.